33.44 - 34.57
31.40 - 61.90
7.61M / 5.95M (Avg.)
-152.73 | -0.22
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
7.55%
Revenue growth under 50% of TOST's 15.93%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
8.14%
Gross profit growth at 50-75% of TOST's 13.29%. Martin Whitman would question if cost structure or brand is lagging.
60.83%
EBIT growth similar to TOST's 62.00%. Walter Schloss might infer both firms share similar operational efficiencies.
61.13%
Operating income growth at 50-75% of TOST's 86.05%. Martin Whitman would doubt the firm’s ability to compete efficiently.
70.37%
Net income growth above 1.5x TOST's 42.86%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
-110.47%
Negative EPS growth while TOST is at 47.37%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-110.47%
Negative diluted EPS growth while TOST is at 47.90%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.84%
Share count expansion well above TOST's 0.87%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
0.84%
Diluted share count expanding well above TOST's 0.33%. Michael Burry would fear significant dilution to existing owners' stakes.
No Data
No Data available this quarter, please select a different quarter.
49.55%
OCF growth under 50% of TOST's 182.28%. Michael Burry might suspect questionable revenue recognition or rising costs.
55.30%
FCF growth under 50% of TOST's 201.45%. Michael Burry would suspect weaker operating efficiencies or heavier capex burdens.
88.33%
10Y revenue/share CAGR under 50% of TOST's 748.84%. Michael Burry would suspect a lasting competitive disadvantage.
88.33%
5Y revenue/share CAGR under 50% of TOST's 748.84%. Michael Burry would suspect a significant competitive gap or product weakness.
35.59%
3Y revenue/share CAGR under 50% of TOST's 101.73%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
166.35%
10Y OCF/share CAGR under 50% of TOST's 462.54%. Michael Burry would worry about a persistent underperformance in cash creation.
166.35%
Below 50% of TOST's 462.54%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
154.90%
3Y OCF/share CAGR under 50% of TOST's 1032.89%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
87.21%
Below 50% of TOST's 218.41%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
87.21%
Below 50% of TOST's 218.41%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
97.82%
Below 50% of TOST's 880.89%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
182.87%
Equity/share CAGR of 182.87% while TOST is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
182.87%
Equity/share CAGR of 182.87% while TOST is zero. Bruce Berkowitz might see a minor advantage that could compound if the firm maintains positive net worth growth.
-46.77%
Negative 3Y equity/share growth while TOST is at 38.88%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
30.94%
AR growth well above TOST's 2.54%. Michael Burry fears inflated revenue or higher default risk in the near future.
-1.16%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
8.61%
Similar asset growth to TOST's 7.92%. Walter Schloss finds parallel expansions or investment rates.
6.12%
75-90% of TOST's 7.73%. Bill Ackman advocates improvements in profitability or buybacks to keep pace in net worth growth.
-6.60%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-4.82%
Our R&D shrinks while TOST invests at 8.33%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.35%
We cut SG&A while TOST invests at 3.77%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.